Galenicum is a global specialty pharmaceutical company founded in Barcelona, Spain, in 2003 with the mission of improving the quality and affordability of pharmaceutical products. It operates as a business ecosystem covering the entire industry value chain, with six businesses spanning development, licensing and supply of pharmaceuticals, manufacturing, and sales and distribution of bioequivalent medicines and specialty dermatological products. The company has a manufacturing facility near Madrid with production capacity of over 50 million packs per year, employs over 800 people, and reports commercial agreements spanning more than 70 countries worldwide. With consolidated revenues of 213 million euros in 2023, it operates across most therapeutic areas and technologies.
| Import | Export |
|---|---|
|
Trade Records
107
|
Trade Records
252
|
|
Suppliers
3
|
Buyers
15
|
|
Latest Import Date
2026-03
|
Latest Export Date
2026-07
|
According to Topease's global trade data, GALENICUM HEALTH exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
Representative importers include:
- SUED & FARGESA AVE MAXIMO GOMEZ ESQ RAMON SANTANA GAZCUE
- GALENICUM VITAE MEXICO S.A. DE C.V.
- SIEGFRIED RHEIN S.A. DE C.V.
These export insights help users understand the GALENICUM HEALTH distribution footprint, product specialization, and shipment scale. Through Topease's deep trade data and trade intelligence capabilities—such as trade flow analysis and market benchmarking—importers and exporters can evaluate downstream demand and identify potential importer relationships.
As an importer, GALENICUM HEALTH sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Representative exporters include:
These import insights help users assess sourcing patterns, supplier concentration, and trade continuity. With Topease's analytical tools—such as sourcing pattern analysis and supply-chain mapping—users can evaluate supplier performance and identify diversification opportunities.
Explore GALENICUM HEALTH's import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
| Exporter | Importer | HS Code | Number of Trade | Amount (USD) | Quantity | Import Port |
|---|---|---|---|---|---|---|
| INDUSTRIAS QUIMICAS FALCON DE MEXICO S.A. DE C.V. | GALENICUM HEALTH | 2937 | 24 | $186,500 | 3,420 | Los Angeles |
| SICOR DE MEXICO S.A. DE C.V. | GALENICUM HEALTH | 2941 | 24 | $186,500 | 3,420 | Los Angeles |
| STADPHARM SDN BHD | GALENICUM HEALTH | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
Gain insights into GALENICUM HEALTH's export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
| Importer | Exporter | HS Code | Number of Trade | Amount (USD) | Quantity | Export Port |
|---|---|---|---|---|---|---|
| SIEGFRIED RHEIN S.A. DE C.V. | GALENICUM HEALTH | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| SUED & FARGESA AVE MAXIMO GOMEZ ESQ RAMON SANTANA GAZCUE | GALENICUM HEALTH | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| LABORATORIOS LEGRAND S. A. | GALENICUM HEALTH | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| NOVUGEN PHARMA MALAYSIA SDN BHD | GALENICUM HEALTH | 3004 | 24 | $186,500 | 3,420 | Los Angeles |
| ACHE LABORATORIOS FARMACEUTICOS SA | GALENICUM HEALTH | 2941 | 24 | $186,500 | 3,420 | Los Angeles |
Chain Insights — Explore GALENICUM HEALTH's trading network to uncover connections with international buyers and suppliers. With Topease's Supply Chain Solution, you can track product flows and identify patterns that reveal new sourcing and partnership opportunities.
Access GALENICUM HEALTH's key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.